Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primovax: GV1001 vs Gemcitabine in Advanced Pancreatic Cancer
NCT00358566Phase 3Terminated
- Sponsor
- Pharmexa
- Start
- Jun 2006
- Primary completion
- Aug 2008
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 12
01
Overview
A Phase 3 trial of tertomotide in pancreatic adenocarcinoma (PDAC), sponsored by Pharmexa. Started Jun 2006; status: terminated.
02
Drugs
tertomotide
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00358566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358566.